- Home
- J&J Innovative Medicine
J&J Innovative Medicine
How surprising new research is tapping the powers of the immune system
Your immune system does so much more than simply fight off colds. For National Autoimmune Disease Awareness Month, we spoke to scientists who are harnessing this vital defense system to fight diseases in ways you likely never imagined.
7 women who are helping to change the world for women
On International Women’s Day, we’re spotlighting inspiring Johnson & Johnson employees who work year-round to improve the health, safety and trajectory of women worldwide.
Thwarting deadly diseases before they start: the new science of cancer interception
Imagine if your doctor could detect cancer before it began growing in your body, then give you medicine to prevent it from taking hold. This researcher explains how she and other scientists are working to someday make this cutting-edge concept a reality.
Janssen Pharmaceuticals releases a 2016 U.S. Transparency Report
Jennifer Taubert, Company Group Chairman, Pharmaceuticals, The Americas, explains why Janssen is sharing information around its medication pricing and other business practices.
Meet Dr. Paul Janssen: a legend in pharmacology
When Janssen Pharmaceuticals merged with Johnson & Johnson in February 1961, a fruitful collaboration that continues to this day was born. Learn about the man who coined over 100 patents and developed more than a dozen life-changing medications.
The next generation of cancer care: How Johnson & Johnson is working to defeat—and even prevent—the disease
From “targeted therapies” to “precision immuno-oncology,” the scientists at Janssen Oncology are looking at cancer treatment from all innovative angles. For National Cancer Prevention Month, they let us in on some of the work they’re doing to help transform cancer care as we know it.
Living with cancer: meet the researcher who went from designing clinical trials to being in one
When Rick Martinez learned he had cancer, his professional life at Johnson & Johnson turned personal: He suddenly found himself the subject of a clinical trial. For National Cancer Prevention Month, he shares his story.
“I escaped war-torn Syria": The story of a Johnson & Johnson refugee scientist
With his hometown of Deir Ezzor plagued by constant fighting, Abdullah Al Hommada had no choice but to flee his country for a chance at a better future outside of Syria. Today, he’s rebuilding his life in Leiden as a Janssen scientist.
3 Entrepreneurs, 3 Big Ideas: Cutting-Edge Cancer, Alzheimer’s and Diabetes Research
They share one thing in common: a goal of transforming the way illnesses are treated in the most forward-thinking way possible. Meet three innovators whose ideas could someday change the future of healthcare.
The new groundbreaking HIV study you need to read about
It’s been two years in the making, but the results of a pre-clinical study on an investigational therapy regimen are in. Co-author Hanneke Schuitemaker shares what researchers have learned.